Sensitized Recipients Exhibit Accelerated but not Hyperacute Rejection of Vascularized Composite Tissue Allografts

Background. Currently, the donor-recipient matching process for vascularized composite tissue allotransplantation (VCTA) closely follows the standard practices for solid organ transplantation. Sensitization is considered a contraindication to VCTA. However, the role of sensitization in VCTA rejection is largely unstudied. Methods. Major histocompatibility-mismatched ACI (RT1a) donors and Wistar Furth (WF) (RT1u) recipients were used to determine whether sensitization would lead to hyperacute rejection in VCTA as in other organs, such as kidneys. WF rats were presensitized to ACI antigens by skin transplantation and received heterotopic osteomyocutaneous VCTA flaps. Kidney transplants served as controls. Results. Production of anti-donor antibody was detected in WF recipients after rejection of the ACI skin grafts. Sensitized WF rats rejected VCTA grafts from ACI rats significantly faster (P<0.05) than unsensitized recipients, but not hyperacutely. Rejection in the sensitized recipients was not prevented by immunosuppression with FK506 and mycophenolate mofetil. In contrast, kidney allografts from ACI rats were hyperacutely rejected within 30 min by sensitized recipients. To confirm the role of antibody-mediated rejection in the sensitized recipients, serum from presensitized rats was adoptively transferred into naïve WF rats. Hyperacute rejection occurred only in transplanted kidneys but not VCTA. Histologic examination of tissues from acceleratedly rejected VCTA showed dense lymphocytic infiltrates, and no antibody deposition. Conclusions. VCTA are rejected in an accelerated fashion but not hyperacutely in the presence of allosensitization and preformed anti-donor antibody. The rejection of VCTA in sensitized recipients is mainly cell mediated and differs mechanistically from that for renal transplants.

[1]  E. Thervet,et al.  Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study , 2010, Transplantation.

[2]  S. Ildstad,et al.  Composite tissue allotransplantation: current challenges. , 2009, Transplantation proceedings.

[3]  Wei-Chao Huang,et al.  Dissociation Between Peripheral Blood Chimerism and Tolerance to Hindlimb Composite Tissue Transplants: Preferential Localization of Chimerism in Donor Bone , 2009, Transplantation.

[4]  S. Ildstad,et al.  Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation. , 2009, Transplantation proceedings.

[5]  P. Chilton,et al.  Strategic Nonmyeloablative Conditioning: CD154:CD40 Costimulatory Blockade at Primary Bone Marrow Transplantation Promotes Engraftment for Secondary Bone Marrow Transplantation after Engraftment Failure1 , 2008, The Journal of Immunology.

[6]  A. Rowshani,et al.  Humoral immunity in renal transplantation: clinical significance and therapeutic approach , 2008, Clinical transplantation.

[7]  K. Ravindra,et al.  Hand transplantation in the United States: experience with 3 patients. , 2008, Surgery.

[8]  C. Magee,et al.  Renal Transplantation in Patients With Positive Lymphocytotoxicity Crossmatches: One Center’s Experience , 2008, Transplantation.

[9]  A. Kirk,et al.  The Banff 2007 Working Classification of Skin‐Containing Composite Tissue Allograft Pathology , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  A. Cooke,et al.  Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide. , 2008, Critical reviews in immunology.

[11]  T. Flotte,et al.  Adeno‐Associated Viral Vector‐Mediated Interleukin‐10 Prolongs Allograft Survival in a Rat Kidney Transplantation Model , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  S. Ildstad,et al.  Transplantation of the hand, face, and composite structures: evolution and current status. , 2007, Clinics in plastic surgery.

[13]  F. Wei,et al.  A modified model of hindlimb osteomyocutaneous flap for the study of tolerance to composite tissue allografts , 2007, Microsurgery.

[14]  L. Xie,et al.  Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy. , 2006, Transplantation proceedings.

[15]  J. Frank,et al.  Composite tissue allotransplantation of the hand and face: a new frontier in transplant and reconstructive surgery , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[16]  W. Baldwin,et al.  Antibody and Complement Mediated Injury in Transplants Following Sensitization by Allogeneic Blood Transfusion , 2006, Transplantation.

[17]  S. Jordan.  IVIG vs. Plasmapheresis for Desensitization: Which Is Better? , 2006, American Journal of Transplantation.

[18]  P. Warner,et al.  ABO-incompatible solid-organ transplantation. , 2006, American journal of clinical pathology.

[19]  M. Haas,et al.  Antibody-mediated rejection in renal allografts: lessons from pathology. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[20]  M. Stegall,et al.  A Comparison of Plasmapheresis Versus High‐Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  C. Magee.  Transplantation across previously incompatible immunological barriers , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[22]  R. Foster,et al.  Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade , 2003, Transplantation.

[23]  M. Umesue,et al.  [Cyclophosphamide-induced immunological tolerance: an overview]. , 1996, Nihon Geka Gakkai zasshi.

[24]  L. Sandu.  Letter: Corticosteroids in Landry-Guillain-Barré-Strohl syndrome. , 1974, Lancet.

[25]  P. Morris,et al.  "Hyperacute" renal-homograft rejection in man. , 1968, The New England journal of medicine.

[26]  O. Fjeldborg,et al.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. , 1966, Lancet.